Drug Research
Developed Antibody Against Coronavirus, “Terrific Breakthrough”: Israel
COVID-19 Vaccine: Israeli Defence Minister Naftali Bennett was shown the "antibody that attacks the virus in a monoclonal way and can neutralize it within the bodies of those ill", a statement from his office said.
Israeli Defence Minister Naftali Bennett...
Drug Research
Trio pharmaceuticals and ajinomoto bio pharma services enter into a development collaboration for a novel antibody therapeutic
Trio Pharmaceuticals, Inc., a cancer therapeutics company developing novel dual action antibody drugs, and Ajinomoto Bio-Pharma Services, have entered a development collaboration to evaluate AJICAP, a site-specific conjugation technology offered by Aji Bio-Pharma for the development of TRIObody Drug...
Drug Research
ProteoGenix to accelerate the discovery of SARS-CoV-2 antibodies with first human immune COVID-19 library
ProteoGenix, a global leader in antibody production, is pleased to announce the first Human Immune COVID-19 library for the fast discovery of potent antibodies against SARS-CoV-2.
"Highly sensitive and specific antibodies are critical for the development of diagnostics, therapeutics, and...
Drug Research
Valo Therapeutics to Support Development of a Pan – Coronavirus Vaccine
Valo Therapeutics Limited (Valo Tx)Â Â announced it is working to develop a potential novel COVID-19 vaccine with applications across future pandemics. Valo Tx will use its PeptiCRAd technology to coat an (undisclosed) adenovirus vaccine vector, engineered to express coronavirus...
Drug Research
NovelStem Announces Collaborations for Stem-Cell Technology Platform in Cancer Immunotherapy and COVID-19 Resistance
NovelStem International Corp. , a biotechnology company focused on its stem cell-based technology platform, developed by Israel-based affiliate, NewStem Ltd., announced two new collaborations to apply NewStem’s technology platform, one to research a potential cancer immunotherapy drug and another...
Drug Research
AdaptVac teams up with AGC Biologics to develop and produce COVID-19 vaccine
AGC Biologics , a leading provider of biopharmaceutical contract development and manufacturing organization (CDMO), announced its partnership with AdaptVac. The partnership was formed to jointly develop and manufacture a COVID-19 vaccine. AdaptVac is developing a SARS-CoV-2 vaccine together with...
Drug Research
CytoSMART to donate 100 live-cell imaging systems to assist COVID-19 researchers
CytoSMART Technologies is to donate 100 mini live-cell imaging systems to researchers in high containment labs worldwide. Labs working to combat COVID-19 will benefit from this initiative, as CytoSMART aims to reduce the huge workload currently facing researchers on projects vital to...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.
Must read
